Air Liquide SA (AI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Air Liquide SA (AI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7472
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Air Liquide SA (Air Liquide) is a provider of gases, technologies and services for industrial and health care sectors. The company produces core air gases such as oxygen, nitrogen, and hydrogen along with argon and other rare gases. It supplies gases to customers in industries, including steel, chemicals, food and pharmaceuticals, electronics, and automotive and manufacturing. Air Liquide also designs and constructs processing facilities and related infrastructure. The company provides skin disinfectants, antiseptics and medical instrument disinfection products. It supplies through on-site facilities, tanker trucks and cylinders. The company has operations across Asia-Pacific, Americas, Europe, Africa and the Middle East. Air Liquide is headquartered in Paris, France.

Air Liquide SA (AI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Air Liquide SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Air Liquide SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Air Liquide SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Air Liquide SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Air Liquide SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Air Liquide SA, Medical Equipment, Deal Details 10
Venture Financing 10
Quanta Fluid Solutions Raises USD43 Million in Series B Venture Financing 10
Partnerships 12
OncoTherapy Science Enters Into Licensing Agreement With Seppic 12
Debt Offering 13
Airgas Completes Public Offering Of Notes Due 2018 For US$325 Million 13
Airgas Completes Public Offering Of Notes Due 2020 For US$275 Million 15
Airgas Completes Public Offering Of Notes Due 2022 For US$250 Million 17
Asset Transactions 19
Praxair Canada Acquires Five Branches In Western Canada From Airgas 19
Acquisition 20
Air Liquide Acquires EOVE 20
Air Liquide Acquires 65% Stake in Optimal Medical Therapies 21
Airgas Acquires Welding & Therapy Service 22
Air Liquide Acquires Ventamed Spolka, Home Healthcare Company 23
Air Liquide Acquires Help!, Home Healthcare Company 24
Air Liquide Acquires 73.3% Stake In Healthy Sleep Solutions 25
Air Liquide Acquires Lentechgas, Medical Gases Provider 26
Air Liquide Acquires 75% Stake In LOGIKA, Industrial Gas Producer 27
Air Liquide SA – Key Competitors 28
Air Liquide SA – Key Employees 29
Air Liquide SA – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Air Liquide SA, Medical Equipment, Key Facts, 2017 2
Air Liquide SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Air Liquide SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Air Liquide SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Air Liquide SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Air Liquide SA, Deals By Market, 2012 to YTD 2018 8
Air Liquide SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Quanta Fluid Solutions Raises USD43 Million in Series B Venture Financing 10
OncoTherapy Science Enters Into Licensing Agreement With Seppic 12
Airgas Completes Public Offering Of Notes Due 2018 For US$325 Million 13
Airgas Completes Public Offering Of Notes Due 2020 For US$275 Million 15
Airgas Completes Public Offering Of Notes Due 2022 For US$250 Million 17
Praxair Canada Acquires Five Branches In Western Canada From Airgas 19
Air Liquide Acquires EOVE 20
Air Liquide Acquires 65% Stake in Optimal Medical Therapies 21
Airgas Acquires Welding & Therapy Service 22
Air Liquide Acquires Ventamed Spolka, Home Healthcare Company 23
Air Liquide Acquires Help!, Home Healthcare Company 24
Air Liquide Acquires 73.3% Stake In Healthy Sleep Solutions 25
Air Liquide Acquires Lentechgas, Medical Gases Provider 26
Air Liquide Acquires 75% Stake In LOGIKA, Industrial Gas Producer 27
Air Liquide SA, Key Competitors 28
Air Liquide SA, Key Employees 29
Air Liquide SA, Subsidiaries 30

List of Figures
Air Liquide SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Air Liquide SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Air Liquide SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Air Liquide SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Air Liquide SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Air Liquide SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Air Liquide SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Air Liquide SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Air Liquide SA (AI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Monster Beverage Corporation:企業の戦略・SWOT・財務情報
    Monster Beverage Corporation - Strategy, SWOT and Corporate Finance Report Summary Monster Beverage Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Fortitech Inc.:戦略・SWOT・企業財務分析
    Fortitech Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortitech Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CardioComm Solutions Inc (EKG):企業の製品パイプライン分析
    Summary CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. It offers software engineering of computer based electrocardiogram management and reporting software. Its produ …
  • Maruzen Petrochemical Co Ltd:企業の戦略的SWOT分析
    Maruzen Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Changmao Biochemical Engineering Co., Ltd:企業の戦略・SWOT・財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Perseus Mining Ltd:企業の戦略・SWOT・財務分析
    Perseus Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Perseus Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Transelectrica SA:企業の発電所・SWOT分析2018
    Transelectrica SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • OBI Pharma Inc (4174):製薬・医療:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報
    Summary Tella Inc (Tella) is a drug development company that develops vaccines for cancer treatment. The company offers dendritic cell vaccine therapy which develops dendritic cells to convey the information on cancer markers to lymphocytes and increase the dendritic cell population and strengthen t …
  • Exxon Mobil Corporation (XOM)-エネルギー分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …
  • Nationwide Financial Services, Inc.:企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Cannabics Pharmaceuticals Inc (CNBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated cellular imaging and analysis platform designed …
  • i-Optics BV:医療機器:M&Aディール及び事業提携情報
    Summary I-Optics BV (I-Optics) is a medical device company that manufactures and distributes optical devices. The company offers Cassini, a corneal shape analyzer that measures the axis and magnitude of corneal astigmatism and EasyScan, a zero-dilation retinal imaging system to diagnose retinal dise …
  • The GPT Group (GPT):企業の財務・戦略的SWOT分析
    The GPT Group (GPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Baptist Memorial Health Care Corp:企業の戦略的SWOT分析
    Baptist Memorial Health Care Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Beacon Discovery Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Beacon Discovery Inc (Beacon Discovery) is an independent drug discovery incubator that focuses on identifying and advancing molecules targeting G-Protein Coupled Receptors (GPCRs) from concept to clinic. The company works in collaboration with pharma and biotech companies to discover and de …
  • Fitbit Inc.:戦略・SWOT・企業財務分析
    Fitbit Inc. - Strategy, SWOT and Corporate Finance Report Summary Fitbit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Allied Irish Banks, Plc:企業のM&A・事業提携・投資動向
    Allied Irish Banks, Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allied Irish Banks, Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Marsulex Environmental Technologies Corp:企業の戦略的SWOT分析
    Marsulex Environmental Technologies Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Curetis NV (CURE):企業の製品パイプライン分析2018
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue inf …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆